TCIRG1 and osteopetrosis: In this paper, we exploited the murine model of Tcirg1-defective osteopetrosis to test the efficacy of ex vivo gene therapy, as well as to optimize the HSPC mobilization and pre-transplant conditioning, fundamental for a successful outcome of the GT protocol.